ArticleOncology letters2026

Construction and validation of a predictive model of pathological complete response combined with MRI and tumor indicators for HER2-positive breast cancer after neoadjuvant targeted therapy.

Keying Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.